Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Topical Advisory Panel
Click here to see the Section Topical Advisory Panel of "Viral Immunology, Vaccines, and Antivirals".
Special Issues
Following special issues within this section are currently open for submissions:
- STING-Mediated Antiviral Activity and Viral Evasion (Deadline: 30 November 2023)
- Pharmacology of Antivirals Targeting Metabolism and Immunity (Deadline: 30 November 2023)
- Recent Advances in the Fight against Respiratory Viruses (Deadline: 30 November 2023)
- Advances and Novel Concepts in Herpesvirus Vaccines (Deadline: 30 November 2023)
- Viral Entry Inhibitors 2023 (Deadline: 30 November 2023)
- Viral Proteases: Modulation of Immune Responses and Antiviral Therapies (Deadline: 30 November 2023)
- Vaccines and Treatments for Viral Hemorrhagic Fevers (Deadline: 10 December 2023)
- Efficacy and Safety of Antiviral Therapy 2nd Edition (Deadline: 15 December 2023)
- Viral Infections and Immune Dysregulation 2023 (Deadline: 15 December 2023)
- Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection (Deadline: 15 December 2023)
- Vaccines against Enveloped RNA Viruses (Deadline: 15 December 2023)
- SARS-CoV-2: Vaccine Design and Host Immunity (Deadline: 15 December 2023)
- Novel and Repurposed Antiviral Agents (Deadline: 16 December 2023)
- Antibody Response to Dengue, Zika and Other Flaviviruses (Deadline: 20 December 2023)
- Innate and Adaptive Immunity to Cutaneous Virus Infection (Deadline: 30 December 2023)
- Virus-Like Particle Vaccines 2023 (Deadline: 30 December 2023)
- Enzymes as Antiviral Targets (Deadline: 31 December 2023)
- Viruses and Virus-Like Particles as Nanoplatforms for Vaccines, Diagnostic and Therapeutic Nanomedicine (Deadline: 31 December 2023)
- Computational Drug Discovery for Viral Infections (Deadline: 31 December 2023)
- Broadly Protective Anti-viral Vaccines (Deadline: 31 December 2023)
- Antivirals against Arboviruses (Deadline: 31 December 2023)
- Universal Influenza Vaccines for Humans and Animals (Deadline: 31 December 2023)
- Current ART, Virologic Failure and Implications for HIV Drug Resistance (Deadline: 6 January 2024)
- Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents (Deadline: 15 January 2024)
- Advances in Antiviral Agents against SARS-CoV-2 and Its Variants 2nd Edition (Deadline: 17 January 2024)
- RNA Viruses and Antibody Response 2nd Edition (Deadline: 31 January 2024)
- Innate Sensing and Restriction of Retroviruses (Deadline: 31 January 2024)
- Roles of Macrophages in Viral Infections (Deadline: 31 January 2024)
- Recent Advances in Antiviral Natural Products 2023 (Deadline: 31 January 2024)
- Control of Viral Epidemics through Vaccination (Deadline: 31 January 2024)
- New Advances in Arbovirus Vaccines (Deadline: 29 February 2024)
- Biologics for Emerging and Reemerging Viral Infections (Deadline: 29 February 2024)
- Antiviral Peptide (Deadline: 1 March 2024)
- Regulation of the Virus Lifecycle by Cellular RNA-Binding Proteins (Deadline: 1 March 2024)
- Integrase Inhibitors 2023 (Deadline: 15 March 2024)
- Host Cell-Virus Interaction 3rd Edition (Deadline: 15 March 2024)
- The Diverse Regulation of Transcription in Endogenous Retroviruses (Deadline: 28 March 2024)
- Unraveling the Pathogenesis of Persistent Virus Infection (Deadline: 31 March 2024)
- Novel Antiviral Targets against Emerging Viruses (Deadline: 31 March 2024)
- T Cells in Viral Infections Volume 2 (Deadline: 31 March 2024)
- Viral Strategies to Regulate Host Immunity or Signal Pathways (Deadline: 31 March 2024)
- Interferon-Induced Transmembrane Proteins at the Intersection of Virus Infection and Immunity (Deadline: 31 March 2024)
- Innate Immunity to Virus Infection 2nd Edition (Deadline: 31 March 2024)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 2.0 (Deadline: 31 March 2024)
- Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation 2nd Edition (Deadline: 31 March 2024)
- Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation 2nd Edition (Deadline: 20 April 2024)
- Chronic Infection by Oncogenic Viruses (Deadline: 30 April 2024)
- Broad-Spectrum Antivirals and Interaction with Viruses (Deadline: 30 April 2024)
- Natural Killer Cell in Viral Infection (Deadline: 30 April 2024)
- CRISPR/Cas in Viral Research 2024 (Deadline: 30 April 2024)
- Rabies Virus: Treatment and Prevention (Deadline: 30 April 2024)
- Antiviral Immune Responses of Bat (Deadline: 30 April 2024)
- Viral Sepsis: Pathogenesis, Diagnostics and Therapeutics (Deadline: 1 May 2024)
- Animal Coronaviruses: Infection, Prevention, and Antivirals (Deadline: 20 May 2024)
- Mucosal Immunity to Respiratory Viruses (Deadline: 31 May 2024)
- Structure-Guided Antiviral Discovery: From Target Validation to Drug Design to Candidate Selection (Deadline: 31 May 2024)
- Advanced Strategies against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks (Deadline: 31 May 2024)
- TRIM Proteins in Antiviral Immunity and Virus Pathogenesis (Deadline: 30 June 2024)
- Immune Responses to Papillomavirus Infections (Deadline: 30 June 2024)
- Epigenetic and Transcriptional Regulation of DNA Virus Infections (Deadline: 30 June 2024)
- B Cell-Mediated Immunity to Viruses (Deadline: 30 June 2024)
- Next Generation Sequencing for HIV Drug Resistance Testing 2nd Edition (Deadline: 30 June 2024)
- Antiviral Resistance Mutations (Deadline: 30 June 2024)
- Innate and Adaptive Immune Responses to Arbovirus Infections (Deadline: 31 July 2024)
- Protein–Protein Interactions in the Discovery of Antiviral Drugs (Deadline: 31 July 2024)
- Pathogenesis of Arbovirus Infections (Deadline: 31 July 2024)
- Elimination of Viral Hepatitis: Improving Diagnosis, Treatment and Surveillance 2.0 (Deadline: 16 August 2024)
- Mechanisms of Herpesvirus Resistance (Deadline: 31 August 2024)
- Viruses, MicroRNAs and Host Interactions (Deadline: 31 August 2024)
- Immunity to Enteric Viruses (Deadline: 30 September 2024)
